Valuation: Guided Therapeutics, Inc.

Market Cap 27.02M 23.61M 21.79M 20.08M 37.86M 2.6B 38.7M 260M 102M 1.27B 101M 99.25M 4.39B P/E 2024
-3x
P/E 2025 -12.7x
Enterprise Value 29.9M 26.13M 24.11M 22.22M 41.89M 2.88B 42.82M 288M 113M 1.41B 112M 110M 4.85B EV / Sales 2024
1,649x
EV / Sales 2025 64.4x
Free-Float
63.48%
Yield 2024 *
-
Yield 2025 -
1 day-1.75%
1 week-8.33%
Current month+14.58%
1 month+3.77%
3 months+37.50%
6 months-28.20%
Current year-49.07%
1 week 0.25
Extreme 0.2531
0.3
1 month 0.2
Extreme 0.2001
0.32
Current year 0.17
Extreme 0.17
0.54
1 year 0.12
Extreme 0.1231
0.54
3 years 0.06
Extreme 0.064
0.54
5 years 0.06
Extreme 0.062
0.78
10 years 0.02
Extreme 0.0206
3,200
Manager TitleAgeSince
Chief Executive Officer 70 2023-03-05
Chief Tech/Sci/R&D Officer 70 2010-12-01
Director TitleAgeSince
Director/Board Member 76 2006-04-09
Director/Board Member 69 2016-11-09
Director/Board Member 70 2016-11-30
Date Insider Type Main position Quantity % Market Cap.
3/10/26 Others

Director

10 0.9747%
3/10/26 Free

Chairman

110,000 0.1316%
3/10/26 Free

Director

110,000 0.1316%
Change 5-day change 1-year change 3-year change Capi.($)
-1.75%-8.33%+17.02%+44.74% 27.02M
-1.20%+0.06%+30.60%-1.75% 198B
-0.62%+1.85%+8.40%-16.58% 144B
-0.25%-14.57%-32.61%+0.04% 122B
-0.37%-1.58%-57.66%-17.80% 65.44B
-0.26%-6.56%+12.02%-7.43% 49.36B
+0.37%-0.87%-23.03%-31.34% 44.74B
+0.16%-1.12%+18.30%+6.42% 37.13B
-1.91%-2.88%+28.69%+29.55% 36.23B
-1.63%-1.35%-24.99%-10.70% 28.7B
Average -0.68%-3.78%-2.33%-0.49% 72.61B
Weighted average by Cap. -0.57%-2.62%+0.09%-6.42%

Financials

2024 2025
Net sales 7K 6.12K 5.64K 5.2K 9.81K 674K 10.02K 67.47K 26.54K 330K 26.29K 25.71K 1.14M 767K 670K 619K 570K 1.07M 73.86M 1.1M 7.39M 2.91M 36.18M 2.88M 2.82M 125M
Net income -2.42M -2.11M -1.95M -1.8M -3.39M -233M -3.46M -23.3M -9.16M -114M -9.08M -8.88M -392M -3.2M -2.79M -2.58M -2.38M -4.48M -308M -4.58M -30.81M -12.12M -151M -12M -11.74M -519M
Net Debt 1.77M 1.55M 1.43M 1.32M 2.48M 171M 2.54M 17.07M 6.71M 83.53M 6.65M 6.51M 288M 2.88M 2.51M 2.32M 2.14M 4.03M 277M 4.12M 27.72M 10.9M 136M 10.8M 10.56M 467M
Logo Guided Therapeutics, Inc.
Guided Therapeutics, Inc. is a medical technology company. The Company is focused on developing medical devices that have the potential to improve healthcare. The Company’s primary focus is the sales and marketing of its LuViva Advanced Cervical Scan non-invasive cervical cancer detection device. The underlying technology of LuViva primarily relates to the use of biophotonics for the non-invasive detection of cancers. LuViva is designed to identify cervical cancers and precancers painlessly, non-invasively and at the point of care by scanning the cervix with light, then analyzing the reflected and fluorescent light. LuViva is designed to provide a less invasive and painless alternative to conventional tests for cervical cancer screening and detection. Additionally, LuViva is designed to improve patient well-being not only because it eliminates pain, but also because it is convenient to use and provides rapid results at the point of care.
Employees
3
Date Price Change Volume
26-07-20 $0.2750 -1.75% 2,200
26-07-16 $0.2799 +3.67% 573
26-07-15 $0.2700 -3.57% 23,501
26-07-14 $0.2800 -6.67% 14,616
26-07-13 $0.3000 0.00% 3,530
  1. Stock Market
  2. Stocks
  3. GTHP Stock